G1 GLP-1 Collective

News & laws

GLP-1 news and law
changes, last 24 hours.

Coverage decisions, bills, lawsuits and FDA action, written for patients rather than lawyers. Updated every day, published here in full, free, with no paywall and no account.

Today’s edition · September 1, 2026

Ozempic Jab’s Creator Needs a Second Act. Pills May Be the Answer.

Read today’s edition

Latest Patient Lens · September 1, 2026

FDA tightens rules on where your GLP-1 actually comes from

New registration requirements for compounding pharmacies could reshape access and pricing.

Read the explainer

Patient Lens is the longer version: what a change actually means for somebody trying to get or keep a prescription.

Laws in your state

Coverage rules are set state by state, so what applies to you depends on where you live. GLP1Laws tracks every bill, lawsuit and coverage decision by state and is free to read.

Check the laws in your state

GLP1Laws and GLP-1 Nation are operated by GLP-1 Studio LLC, a for-profit company founded by the Collective’s Executive Director. Both are free to read, carry no paywall and sell nothing, and they are funded by sponsorship and donations. Their reporting is republished here in full with attribution. The Collective pays nothing for it and receives no payment, commission or referral fee. How this works.

Earlier

Evening Edition

Patient Lens

Want it in your inbox instead? Email updates carry the changes that affect access.